Oransky I. Retractions are increasing, but not enough. Nature. 2022;608(7921):9.
Article CAS PubMed Google Scholar
Brainard J. Rethinking retractions. Science. 2018;362(6413):390–3.
Article CAS PubMed Google Scholar
Cokol M, Ozbay F, Rodriguez-Esteban R. Retraction rates are on the rise. EMBO Rep. 2008;9(1):2–2.
Article CAS PubMed PubMed Central Google Scholar
Petrou C. Making sense of retractions and tackling research misconduct. The Scholarly Kitchen 2024; Available from: https://scholarlykitchen.sspnet.org/2024/04/18/guest-post-making-sense-of-retractions-and-tackling-research-misconduct/.
Moylan EC, Kowalczuk MK. Why articles are retracted: a retrospective cross-sectional study of retraction notices at BioMed Central. BMJ Open. 2016;6(11):e012047.
Article PubMed PubMed Central Google Scholar
Hwang SY, et al. Causes for retraction in the biomedical literature: a systematic review of studies of retraction notices. J Korean Med Sci. 2023;38(41):e333.
Article PubMed PubMed Central Google Scholar
Wager E, et al. Retractions: guidance from the Committee on Publication Ethics (COPE). Croat Med J. 2009;50(6):532–5.
Article PubMed PubMed Central Google Scholar
Hsiao TK, Schneider J. Continued use of retracted papers: temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine. Quant Sci Stud. 2022;2(4):1144–69.
Article PubMed PubMed Central Google Scholar
Thompson JC, et al. MSR120 to include an error once may be regarded as a misfortune, to include it again looks like carelessness. Value Health. 2022;25(12):S373.
Article PubMed Central Google Scholar
Bozzo A, et al. Retractions in cancer research: a systematic survey. Res Integr Peer Rev. 2017;2:5.
Article PubMed PubMed Central Google Scholar
El-Menyar A, et al. Publications and retracted articles of COVID-19 pharmacotherapy-related research: a systematic review. Sci Prog. 2021;104(2):368504211016936.
Article CAS PubMed Google Scholar
Capodici A, et al. Biased, wrong and counterfeited evidences published during the COVID-19 pandemic, a systematic review of retracted COVID-19 papers. Qual Quant. 2022;57:4881–913.
Kataoka Y, et al. Retracted randomized controlled trials were cited and not corrected in systematic reviews and clinical practice guidelines. J Clin Epidemiol. 2022;150:90–7.
Shahraki-Mohammadi A, Keikha L, Zahedi R. Investigate the relationship between the retraction reasons and the quality of methodology in non-Cochrane retracted systematic reviews: a systematic review. Syst Rev. 2024;13(1):24.
Article PubMed PubMed Central Google Scholar
Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
Karabag SF, Berggren C. Misconduct, marginality and editorial practices in management, business and economics journals. PLoS ONE. 2016;11(7):e0159492.
Article PubMed PubMed Central Google Scholar
Cox A, Craig R, Tourish D. Retraction statements and research malpractice in economics. Res Policy. 2018;47(5):924–35.
Abbott DE, et al. How much should we pay to minimize pancreatic leak? The cost-effectiveness of pasireotide in pancreatic resection: RETRACTED. Ann Surg. 2016. https://doi.org/10.1097/SLA.0000000000001411.
Retraction: The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK. BJU Int. 2018;122(2): E3.
Sampson CJ, Wrightson T. Model registration: a call to action. PharmacoEconomics - Open. 2017;1(2):73–7.
Article PubMed PubMed Central Google Scholar
Christensen G, Miguel E. Transparency, reproducibility, and the credibility of economics research. J Econ Lit. 2018;56(3):920–80.
Necker S. Scientific misbehavior in economics. Res Policy. 2014;43(10):1747–59.
Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
Article PubMed PubMed Central Google Scholar
da Teixeira Silva JA, Dobránszki J. Notices and policies for retractions, expressions of concern, errata and corrigenda: their importance, content, and context. Sci Eng Ethics. 2017;23(2):521–54.
Zilberman T, et al. Retracted publications in infectious diseases and clinical microbiology literature: an analysis using the retraction watch database. Clin Microbiol Infect. 2023;29(11):1454.e1-1454.e3.
Article CAS PubMed Google Scholar
Glanville J, Kaunelis D, Mensinkai S. How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE. Int J Technol Assess Health Care. 2009;25(4):522–9.
Fang FC, Steen RG, Casadevall A. Misconduct accounts for the majority of retracted scientific publications. Proc Natl Acad Sci USA. 2012;109(42):17028–33.
Article CAS PubMed PubMed Central Google Scholar
Haddaway NR, Grainger MJ, Gray CT. Citationchaser: a tool for transparent and efficient forward and backward citation chasing in systematic searching. Res Synth Methods. 2022;13(4):533–45.
Lamotte M, et al. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction. Herz. 2006;31(Suppl 3):74–82.
Lamotte MA, Kawalec Ll, Zoellner Y. RETRACTED ARTICLE: a multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction. Herz. 2014;39:219–21.
Quinonez R, Stearns SC. Issues and early evidence for the economic evaluation of the effects of periodontal therapy on pregnancy outcomes. J Periodontol. 2008;79(2):203–6.
Quinonez R, Stearns SC. RETRACTED: issues and early evidence for the economic evaluation of the effects of periodontal therapy on pregnancy outcomes. (J Periodontol 2008;79:203-206). J Periodontol. 2008;79(5):771.
Arreola-Ornelas H, Lemus-Carmona EA, Camacho-Cordero LM. RETRACTED: Evaluación económica de ranibizumab en pacientes adultos con degeneración macular relacionada con la edad (DMRE) exudativa en México. Rev Mex Oftalmol. 2014;88(1):5–15.
Retracted: Impact of Type 2 diabetes prevention programmes based on risk identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabet Med. 2016;33(8):1155–63.
Sowa PM, Downes MJ, Gordon LG. RETRACTED ARTICLE: Cost-effectiveness of dual energy X-ray absorptiometry (DXA) plus anti-resorptive treatment in Australian women with breast cancer who receive aromatase inhibitors. J Bone Miner Metab. 2016;34(2):242–242.
Leung HW, Chan AL, Wang SY. RETRACTED: cost-utility analysis of trastuzumab combined with Docetaxel for patients with HER-2 positive metastatic breast cancer—real world claim data. J Oncol Pharm Pract. 2018;24(6):Np2-np8.
Retraction notice. J Oncol Pharm Pract. 2018;24(6):Np1.
Autiero SW, et al. The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK. BJU Int. 2015;116(6):945–54.
Article CAS PubMed Google Scholar
Ademi Z, et al. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment? Atherosclerosis. 2020;304:1–8.
Comments (0)